AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022

Nina Ditsch, Achim Wöcke, Michael Untch, Christian Jackisch, Ute-Susann Albert, Maggie Banys-Paluchowski, Ingo Bauerfeind, Jens-Uwe Blohmer, Wilfried Budach, Peter Dall, Eva Maria Fallenberg, Peter A Fasching, Tanja N Fehm, Michael Friedrich, Bernd Gerber, Oleg Gluz, Nadia Harbeck, Jörg Heil, Jens Huober, Hans H KreipeDavid Krug, Thorsten Kühn, Sherko Kümmel, Cornelia Kolberg-Liedtke, Sibylle Loibl, Diana Lüftner, Michael Patrick Lux, Nicolai Maass, Christoph Mundhenke, Ulrike Nitz, Tjoung-Won Park-Simon, Toralf Reimer, Kerstin Rhiem, Achim Rody, Marcus Schmidt, Andreas Schneeweiss, Florian Schütz, Hans-Peter Sinn, Christine Solbach, Erich-Franz Solomayer, Elmar Stickeler, Christoph Thomssen, Isabell Witzel, Volkmar Müller, Wolfgang Janni, Marc Thill


INTRODUCTION: The AGO (Arbeitsgemeinschaft Gynäkologische Onkologie, German Gynecological Oncology Group) Task Force on Diagnosis and Treatment of Breast Cancer as an interdisciplinary team consists of specialists from gynecological oncology, pathology, diagnostic radiology, medical oncology, and radiation oncology with a special focus on breast cancer.

METHODS: The updated evidence-based treatment recommendation 2022 for early breast cancer (EBC) and metastatic breast cancer of the AGO Task Force has been released.

RESULTS AND CONCLUSION: This paper captures the update of EBC.

Original languageEnglish
JournalBreast Care
Issue number4
Pages (from-to)403-420
Number of pages18
Publication statusPublished - 08.2022

Research Areas and Centers

  • Centers: University Cancer Center Schleswig-Holstein (UCCSH)
  • Research Area: Luebeck Integrated Oncology Network (LION)


Dive into the research topics of 'AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022'. Together they form a unique fingerprint.

Cite this